Interpace Biosciences, Inc. (IDXG)

Interpace Biosciences Revenue

Interpace Biosciences had revenue of $8.76M in the quarter ending September 30, 2025, a decrease of -28.78%. This brings the company's revenue in the last twelve months to $41.92M, down -6.06% year-over-year. In the year 2024, Interpace Biosciences had annual revenue of $46.93M with 17.21% growth.

• Revenue (ttm): 41.92M
• Revenue Growth: -6.06%
• P/S Ratio: 1.18
• Revenue / Employee: 377.61K
• Employees: 111
• Market Cap: 49.30M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	46.93M	6.89M	17.21%
Dec 31, 2023	40.04M	8.20M	25.75%
Dec 31, 2022	31.84M	-1.28M	-3.86%
Dec 31, 2021	33.12M	719.00K	2.22%
Dec 31, 2020	32.40M	8.18M	33.77%